Investor · San Francisco, CA

Jonathan Root

Open Jonathan in the network graph →

Filings

20

SEC Form D

Connections

115

co-filers

Capital

$288.2M

across filings

Active

Dec 2010

to Jul 2025

Most-connected co-filers (115)

Kirk Nielsen · Fremont, CA9 shared Peter Thompson · New York, NY7 shared Brian Cox · Aliso Viejo, CA7 shared Donald Milder · Aliso Viejo, CA7 shared Robert Rosenbluth · Aliso Viejo, CA4 shared Paul Lubock · Aliso Viejo, CA4 shared Stephen A. Martin · Denver, CO3 shared R. D. Higgins · Denver, CO3 shared Ali Wasti · Denver, CO3 shared Anish K. Bahl · New York, NY3 shared Alexei Mlodinow · Chicago, IL3 shared Brian Mankwitz · Denver, CO3 shared Adam T. Krynicki · Fairbanks, AK3 shared Global Credit Advisers, LLC · New York, NY3 shared Stacey A. Giard · Denver, CO3 shared Patrick Quinlan · Denver, CO3 shared William H. Hoffman · Irvine, CA3 shared John B. Fitzgibbons · New York, NY3 shared Scott E. Couto · Smithfield, RI3 shared Laura Shawver · Burlingame, CA3 shared Eric N. Assimakopoulos · Aventura, FL2 shared Barry G. Mcclay · Torteval, Y72 shared Garry R. Jensen · London, United Kingdom2 shared Jason Pecora · New York, NY2 shared

Recent filings (20)

Sparrow Pharmaceuticals, Inc.Jul 2025 · 13 co-filers$121.4M Sparrow Pharmaceuticals, Inc.Jul 2025 · 13 co-filers$121.4M Sparrow Pharmaceuticals, Inc.Apr 2024 · 9 co-filers$15.3M Sparrow Pharmaceuticals, Inc.Apr 2024 · 9 co-filers$15.3M Edgewise Therapeutics, Inc.Dec 2020 · 14 co-filers$95.0M Silverback Therapeutics, Inc.Oct 2020 · 15 co-filers$85.0M Silverback Therapeutics, Inc.Oct 2020 · 15 co-filers$85.0M Silverback Therapeutics, Inc.Mar 2020 · 9 co-filers$78.7M Silverback Therapeutics, Inc.Mar 2020 · 9 co-filers$78.7M Swoop.com, IncFeb 2020 · 8 co-filers$3.0M Swoop.com, IncFeb 2020 · 8 co-filers$3.0M Cleave Biosciences, Inc.Jun 2019 · 9 co-filers$20.8M Cleave Biosciences, Inc.Jun 2019 · 9 co-filers$20.8M Inari Medical, Inc.Apr 2018 · 18 co-filers$27.0M Cleave Biosciences, Inc.Aug 2016 · 19 co-filers$36.8M Cleave Biosciences, Inc.Aug 2016 · 19 co-filers$36.8M REVETAS CAPITAL FUND II (NO.1) L.P.May 2016 · 12 co-filers$318.0M Alden Global CRE Opportunities Fund, LPMay 2016 · 5 co-filers Inari Medical, Inc.Dec 2015 · 18 co-filers$6.1M Omada Health, Inc.Oct 2015 · 15 co-filers$48.7M Inari Medical, Inc.Jul 2015 · 18 co-filers$12.4M Alden Global CRE Opportunities Fund, LPMay 2015 · 5 co-filers REVETAS CAPITAL FUND II (NO.1) L.P.May 2015 · 12 co-filers$318.0M OncoMed Pharmaceuticals IncDec 2013 · 21 co-filers$22.2M OncoMed Pharmaceuticals IncDec 2013 · 21 co-filers$22.2M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Jonathan in the interactive graph →